Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
27.01
+0.36 (1.35%)
At close: Aug 6, 2026, 4:00 PM EDT
26.94
-0.07 (-0.26%)
After-hours: Aug 6, 2026, 7:34 PM EDT
Cue Biopharma Market Cap
Cue Biopharma has a market cap or net worth of $113.45 million as of August 6, 2026. Its market cap has increased by 97.65% in one year.
Market Cap
113.45M
Enterprise Value
99.45M
1-Year Change
97.65%
Ranking
Category
Stock Price
$27.01
ChartMarket Cap Chart
Since January 2, 2018, Cue Biopharma's market cap has decreased from $193.50M to $113.45M, a decrease of -41.37%. That is a compound annual growth rate of -6.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 107.80M | 349.17% |
| Dec 31, 2025 | 24.00M | -65.27% |
| Dec 31, 2024 | 69.10M | -41.98% |
| Dec 29, 2023 | 119.10M | 18.15% |
| Dec 30, 2022 | 100.80M | -71.94% |
| Dec 31, 2021 | 359.20M | -5.17% |
| Dec 31, 2020 | 378.80M | 3.78% |
| Dec 31, 2019 | 365.00M | 285.84% |
| Dec 31, 2018 | 94.60M | -51.11% |
| Jan 2, 2018 | 193.50M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ProMIS Neurosciences | 121.69M |
| Seer, Inc. | 121.51M |
| Vivani Medical | 120.73M |
| enGene Therapeutics | 118.91M |
| Anixa Biosciences | 116.02M |
| Rani Therapeutics Holdings | 111.81M |
| Fractyl Health | 108.67M |
| Coya Therapeutics | 107.20M |